Quantitative real-time PCR analysis demonstrated that eNOS expression was upregulated in the CAD+ group in comparison with control people (Figure 1); however, in spite of the fact that an upregulated expression was detected, it was not statistically significant in the 0.05 significance level (P = 0.29). The gene discussed is NOS3; the disease is coronary artery disorder.